← Eichor
Condition: Human Papilloma Virus Hpv Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Human Papilloma Virus Hpv

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts
Phase 2 · 1 location(s) · Zagazig University · NCT05291845Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
Phase 2 · 2 location(s) · University of Maryland, Baltimore · NCT06624839High Resolution Anuscopy Study
Phase N/A · 1 location(s) · Universitair Ziekenhuis Brussel · NCT06697964HPV-based Screening Among Women 23-29 Years of Age
NA · 2 location(s) · Karolinska Institutet · NCT05229679Normalizing Antibody Detection in First-void Urine
Phase N/A · 1 location(s) · Universiteit Antwerpen · NCT06582654Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
Phase N/A · 3 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT04564989The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)
Phase 2 · 2 location(s) · Icahn School of Medicine at Mount Sinai · NCT05419089De-escalation of Adjuvant Radiation for Low-Risk HPV Oropharyngeal Cancers
NA · 1 location(s) · Georgetown University · NCT06554158Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After H
Phase 2 · 3 location(s) · Universiteit Antwerpen · NCT07407569Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
Phase 2 · 3 location(s) · Mayo Clinic · NCT05541016Strengthening HPV Immunization Through EPI Leveraged Delivery
Phase 2 · 1 location(s) · International Vaccine Institute · NCT07377656Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)
Phase 2 · 1 location(s) · Medical University of South Carolina · NCT07513389Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vac
Phase 4 · 1 location(s) · Xiamen Innovax Biotech Co., Ltd · NCT07668271Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel
Phase 2 · 1 location(s) · KTH Biopharma · NCT07698886Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India
NA · 3 location(s) · University of California, Irvine · NCT07209917PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia
Phase 2 · 10 location(s) · PapiVax Biotech, Inc. · NCT07454915Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05026138Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07209189HPV Genotype Attribution and Disease Burden of Anal Cancer in China
Phase N/A · 1 location(s) · Fudan University · NCT06670495Stories to Prevent (StoP) HPV Cancers
NA · 1 location(s) · Milton S. Hershey Medical Center · NCT06808776Treatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receivi
NA · 2 location(s) · Georgetown University · NCT06902623Impact of Human Papillomavirus Carriage on IVF/ICSI Results (HPV AMP)
Phase N/A · 1 location(s) · University Hospital, Brest · NCT06550531Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery
Phase 1 · 1 location(s) · Ryan Carey · NCT06747390Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections.
Phase 4 · 12 location(s) · Labo'Life · NCT04232917Digital Telecytology for Triage of HPV-Positive Women in Cameroon
NA · 2 location(s) · University Hospital, Geneva · NCT07550010A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06984861A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Meta
Phase 2 · 25 location(s) · Regeneron Pharmaceuticals · NCT06769698"Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With
NA · 1 location(s) · Johns Hopkins Bloomberg School of Public Health · NCT06587243Patients With Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide C
Phase N/A · 1 location(s) · Regina Elena Cancer Institute · NCT06821243
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.